The APOE polymorphism and 1-year outcome in ischemic stroke: Genotype-gender interaction

Acta Neurologica Scandinavica

Volumn 116, Issue 6, 2007, Pages 392-398

  Gromadzka, G ^a,b   Baranska Gieruszczak, M ^a   Sarzynska Dlugosz, I ^a   Ciesielska, A ^a,b   Czlonkowska, A ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Apolipoprotein E; Gender; Outcome; Polymorphism; Stroke

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; FUNCTIONAL DISEASE; GENDER; GENE INTERACTION; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PREDICTION; PROTEIN POLYMORPHISM; SEX DIFFERENCE;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN ISCHEMIA; DISABILITY EVALUATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ISOFORMS; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; SEX FACTORS; STROKE;

EID: 35748961097     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00880.x     Document Type: Article

References (52)

1. Huang Y, Weisgraber KH, Mucke L, Mahley RW. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci 2004 23 : 189 204.
2. Pankratz N, Byder L, Halter C et al. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Mov Disord 2006 21 : 45 9.
3. Li YJ, Hauser MA, Scott WK et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 2004 62 : 2005 9.
4. Fazekas F, Strasser-Fuchs S, Kollegger H et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 2001 57 : 853 7.
5. Li YJ, Pericak-Vance MA, Haines JL et al. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics 2004 5 : 209 13.
6. Mccarron MO, Weir CJ, Muir KW et al. Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage. Acta Neurol Scand 2003 107 : 106 9.
7. Mccarron MO, Muir KW, Weir CJ et al. The Apolipoprotein E epsilon 4 allele and outcome in cerebrovascular disease. Stroke 1998 29 : 1882 7.
8. Teasdale GM, Murray GD, Nicoli AR. The association between APOE e4, age and outcome after head injury: a prospective cohort study. Brain 2005 128 : 2556 61.
9. Chiang MF, Chang JG, Hu CJ. Association between apolipoprotein E genotype and outcome of traumatic brain injury. Acta Neurochir (Wien) 2003 145 : 649 53.
10. Crawford FC, Vanderploeg RD, Freeman MJ et al. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 2002 58 : 1115 8.
11. Gromadzka G, Baranska-Gieruszczak M, Ciesielska A, Sarzynska-Dlugosz I, Czlonkowska A. APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke in men and women. Cerebrovasc Dis 2005 20 : 291 8.
12. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996 14 : 55 61.
13. Lynch JR, Morgan D, Mance J, Matthew WD, Laskowitz DT. Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J Neuroimmunol 2001 114 : 107 13.
14. Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997 388 : 878 81.
15. Guo L, Ladu MJ, Van Eldik LJ. A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity. J Mol Neurosci 2004 23 : 205 12.
16. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 2006 103 : 5644 51.
17. Laskowitz DT, Fillit H, Yeung N, Toku K, Vitek MP. Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease. Acta Neurol Scand Suppl 2006 185 : 15 20.
18. Weir CJ, Mccarron MO, Muir KW et al. Apolipoprotein E genotype, coagulation, and survival following acute stroke. Neurology 2001 57 : 1097 100.
19. Mccarron MO, Muir KW, Nicoll JA et al. Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Arch Neurol 2000 57 : 1480 4.
20. Catto AJ, Mccormack LJ, Mansfield MW et al. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand 2000 101 : 399 404.
21. Ghebremedhin E, Schultz C, Thal DR et al. Gender and age modify the association between APOE and AD-related neuropathology. Neurology 2001 56 : 1696 701.
22. Mortensen EL, Hogh PA. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 2001 57 : 89 95.
23. Scuteri A, Bos AJ, Zonderman AB et al. Is the apoE4 allele an independent predictor of coronary events? Am J Med 2001 110 : 28 32.
24. World Health Organization (WHO). International Classification of Impairments, Disabilities and Handicaps. Geneva : World Health Organization, 1980.
25. Foulkes M, Wolf P, Price T. Stroke Data Bank: design, methods, and baseline characteristic. Stroke 1988 19 : 547 54.
26. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke-background and study protocol. Stroke 1985 16 : 885 90.
27. Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Maryland State Med J 1965 14 : 56 61.
28. Van Swieten JC, Koudstaal PJ, Visser MC. Intraobserver agreement for the assessment of handicap in stroke patients. Stroke 1988 19 : 604 7.
29. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990 31 : 545 8.
30. Roberts L, Counsell C. Assessment of clinical outcomes in acute stroke trials. Stroke 1998 29 : 986 91.
31. Dziedzic T, Słowik A, Gryz EA. Lower serum triglyceride level is associated with increased stroke severity. Stroke 2004 35 : e151 2.
32. Horsburgh K, Kelly S, Mcculloch J et al. Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia. Neuroreport 1999 10 : 837 41.
33. Sheng H, Laskowitz DT, Mackensen GB et al. Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. Stroke 1999 30 : 1118 24.
34. Coll BW, Mcgregor AL, Wong A et al. APOE varepsilon3 gene transfer attenuates brain damage after experimental stroke. J Cereb Blood Flow Metab 2007 27 : 477 87 (Epub ahead of print).
35. Horsburgh K, Mccarron MO, White F, Nicoll JA. The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol Aging 2000 21 : 245 55.
36. Horsburgh K, Graham DI, Stewart J, Nicoll JA. Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia. J Neuropathol Exp Neurol 1999 58 : 227 34.
37. Fleisher A, Grundman M, Jack cr JR et al. Alzheimer's Disease Cooperative Study. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol 2005 62 : 953 7.
38. Dal Forno G, Carson KA, Brookmeyer R et al. APOE genotype and survival in men and women with Alzheimer's disease. Neurology 2002 58 : 1045 50.
39. Martorell L, Virgos C, Valero J et al. Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it. Mol Psychiatry 2001 6 : 307 10.
40. Buchanan DD, Silburn PA, Prince JA, Mellick GD. Association of APOE with Parkinson disease age-at-onset in women. Neurosci Lett 2007 411 : 185 8.
41. Watson MA, Gay L, Stebbings WS et al. Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis. Clin Sci (Lond) 2003 104 : 537 45.
42. Frikke-Schmidt R, Tybjaerg-Hansen A, Steffensen R, Jensen G, Nordestgaard BG. Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 2000 35 : 1192 9.
43. Schaefer EJ, Lamon-Fava S, Johnson S et al. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler Thromb 1994 14 : 1105 13.
44. Vauthey C, De Freitas GR, Van Melle G, Devuyst G, Bogousslavsky J. Better outcome after stroke with higher serum cholesterol levels. Neurology 2000 54 : 1944 9.
45. Zuliani G, Cherubini A, Atti AR et al. Low cholesterol levels are associated with short-term mortality in older patients with ischemic stroke. J Gerontol A Biol Sci Med Sci 2004 59 : 293 7.
46. Phillips NR, Havel RJ, Kane JP. Sex-related differences in the concentrations of apolipoprotein E in human blood plasma and plasma lipoproteins. J Lipid Res 1983 24 : 1525 31.
47. Raber J, Bongers G, Lefevour A, Buttini M, Mucke L. Androgens protect against apolipoprotein E4-induced cognitive deficits. J Neurosci 2002 22 : 5204 9.
48. Zofkova I, Zajickova K, Hill M, Horinek A. Apolipoprotein E gene determines serum testosterone and dehydroepiandrosterone levels in postmenopausal women. Eur J Endocrinol 2002 147 : 503 6.
49. Simpson E, Rubin G, Clyne C et al. Local estrogen biosynthesis in males and females. Endocr Relat Cancer 1999 6 : 131 7.
50. Colton CA, Brown CM, Vitek MP. Sex steroids, APOE genotype and the innate immune system. Neurobiol Aging 2005 263 : 363 72.
51. Rallidis LS, Vikelis M, Panagiotakos DB. Inflammatory markers and in- hospital mortality in acute ischaemic stroke. Atherosclerosis 2006 189 : 193 7.
52. Sotgiu S, Zanda B, Marchetti B et al. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 2006 13 : 505 13.